Caris Life Sciences (CAI) Free Cash Flow (2024 - 2026)

Caris Life Sciences' Free Cash Flow history runs 3 years deep, the most recent figure standing at $22.5 million for Q1 2026.

• In Q1 2026, Free Cash Flow rose 166.22% year-over-year to $22.5 million; the TTM figure through Mar 2026 stood at $123.5 million (up 188.12% YoY), while the FY2025 annual figure was $66.9 million, up 127.06% from the prior year.
• Free Cash Flow was $22.5 million for Q1 2026 at Caris Life Sciences, down from $39.7 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $55.3 million in Q3 2025 to a low of -$71.3 million in Q3 2024.
• Historically, Free Cash Flow has averaged -$2.4 million across 3 years, with a median of $5.9 million in 2025.
• The sharpest annual moves came in 2025 and 2026: Free Cash Flow surged 213.99% in 2025, then surged 166.22% in 2026.
• A 3-year view of Free Cash Flow shows it stood at -$34.8 million in 2024, then soared by 213.99% to $39.7 million in 2025, then tumbled by 43.22% to $22.5 million in 2026.
• The last three Free Cash Flow figures came in at $22.5 million (Q1 2026), $39.7 million (Q4 2025), and $55.3 million (Q3 2025), per Business Quant data.